You are here

  • Home
  • Online First
  • FOXA2 prevents hyperbilirubinaemia in acute liver failure by maintaining apical MRP2 expression

Article info

Article menu
Download PDFPDF
Hepatology
Original research
FOXA2 prevents hyperbilirubinaemia in acute liver failure by maintaining apical MRP2 expression

Authors

  • Sai Wang Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Rilu Feng Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Shan Shan Wang Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, GermanyBeijing Institute of Hepatology, Beijing You'an Hospital, Capital Medical University, Beijing, China PubMed articlesGoogle scholar articles
  • Hui Liu Department of Pathology, Beijing You’an Hospital, Affiliated with Capital Medical University, Beijing, China PubMed articlesGoogle scholar articles
  • Chen Shao Department of Pathology, Beijing You’an Hospital, Affiliated with Capital Medical University, Beijing, China PubMed articlesGoogle scholar articles
  • Yujia Li Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Frederik Link Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Stefan Munker Department of Medicine II, University Hospital, LMU, Munich, GermanyLiver Center Munich, University Hospital, LMU, Munich, Germany PubMed articlesGoogle scholar articles
  • Roman Liebe Clinic of Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University, Düsseldorf, GermanyDepartment of Medicine II, Saarland University Medical Centre, Saarland University, Homburg, Germany PubMed articlesGoogle scholar articles
  • Christoph Meyer Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Elke Burgermeister Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Matthias Ebert Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, GermanyMannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, Heidelberg University, Mannheim, GermanyClinical Cooperation Unit Healthy Metabolism, Center of Preventive Medicine and Digital Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Steven Dooley Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Huiguo Ding Department of Gastroenterology and Hepatology, Beijing You’an Hospital, Affiliated with Capital Medical University, Beijing, China PubMed articlesGoogle scholar articles
  • Honglei Weng Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Honglei Weng, Department of Medicine II, Section Molecular Hepatology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; honglei.weng{at}medma.uni-heidelberg.de
View Full Text

Citation

Wang S, Feng R, Wang SS, et al
FOXA2 prevents hyperbilirubinaemia in acute liver failure by maintaining apical MRP2 expression
Gut Published Online First: 20 April 2022. doi: 10.1136/gutjnl-2022-326987

Publication history

  • Received January 17, 2022
  • Accepted April 4, 2022
  • First published April 20, 2022.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.